| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000020741 |
| Receipt No. | R000023937 |
| Scientific Title | The effectiveness of oncothermia for the advanced cancer (solid tumor) |
| Date of disclosure of the study information | 2016/01/26 |
| Last modified on | 2021/03/22 (Ver. 11) |
| Basic information | ||
| Public title | The effectiveness of oncothermia for the advanced cancer (solid tumor) | |
| Acronym | Oncothermia research | |
| Scientific Title | The effectiveness of oncothermia for the advanced cancer (solid tumor) | |
| Scientific Title:Acronym | Oncothermia research | |
| Region |
|
|
| Condition | ||||||||||
| Condition | Advanced Cancer (Solid Tumor) | |||||||||
| Classification by specialty |
|
|||||||||
| Classification by malignancy | Malignancy | |||||||||
| Genomic information | NO | |||||||||
| Objectives | |
| Narrative objectives1 | The evaluation of the safty and effectiveness of the oncothermia for the advanced cancer |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Phase I,II |
| Assessment | |
| Primary outcomes | Responce evaluation citeria in solid tumor (RECIST) within 1 month after intervention |
| Key secondary outcomes | Performane status (ECOG) within 1 month after intervention |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Oncothermia (1hr/1 time), 2 times a week. Highest energy is 140 W. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Malignant tumor with histopathological diagnosis
2)Non-responders by standard treatment 3)Informed consent is taken |
|||
| Key exclusion criteria | 1)with obvious infection
2)with severe low-level of nutrition 3)with other severe complication 4)with severe psychological disorder 5)pregnant woman/ with a baby 6)inadequate case by the doctor |
|||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | University of Toyama | ||||||
| Division name | Human Science 1 | ||||||
| Zip code | |||||||
| Address | 2630 Sugitani, Toyama | ||||||
| TEL | 076-434-7405 | ||||||
| kanamori@med.u-toyama.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | University of Toyama | ||||||
| Division name | Human Science 1 | ||||||
| Zip code | |||||||
| Address | 2630 Sugitani, Toyama | ||||||
| TEL | 076-434-7405 | ||||||
| Homepage URL | |||||||
| kanamori@med.u-toyama.ac.jp | |||||||
| Sponsor | |
| Institute | Human Science 1, University of Toyama |
| Institute | |
| Department | |
| Funding Source | |
| Organization | University of Toyama |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 富山大学附属病院(富山県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000023937 |